| August 29, 2025 |
Corporate Report 2025 (Annual Report FY2024) (pdf, 1.2MB) |
| July 31, 2025 |
Summary of Consolidated Financial Results for the First Quarter of FY2025. (pdf, 175KB) |
| July 31, 2025 |
First quarter business summary FY2025. (pdf, 549KB) |
| June 5, 2025 |
Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income) (pdf, 149KB) |
| May 27, 2025 |
Notice of the 93rd Ordinary General Meeting of Shareholders. (pdf, 708KB) |
| May 14, 2025 |
Summary of Consolidated Financial Results for the Fiscal Year 2024. (pdf, 257KB) |
| May 14, 2025 |
Business summary FY2024. (pdf, 1,200KB) |
| April 21, 2025 |
Discovery that citrate, which keeps the body's internal environment weakly alkaline, is effective in preventing or treating peripheral neuropathy induced by anticancer drugs. (pdf, 445KB) |
